Penumbra Investor Relations Material
Latest events
Q1 2025
Penumbra
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Penumbra Inc
Access all reports
Penumbra Inc designs, develops, and markets medical devices for neurovascular and vascular conditions. Its products support treatments for stroke, peripheral embolization, and thrombectomy procedures, serving healthcare providers and hospitals worldwide. Penumbra operates within the healthcare and medical device sectors. The company is headquartered in Alameda, California, and its shares are listed on the NYSE.
Key slides for Penumbra Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Penumbra Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Penumbra Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PEN
Country
🇺🇸 United States